In
the present study, a dinuclear bis(μ-acetate) dicopper(II)
complex [Cu2L2(μ1.1-CH3COO–)2] has been synthesized
from a tridentate NNO Schiff Base ligand L (L = 2,4-dibromo-6-((3-(methylamino)propylimino)methyl)phenol)
and characterized by elemental, ultraviolet–visible (UV–vis),
Fourier transform infrared (FTIR), 1H NMR, and electrospray
ionization-mass spectrometry (ESI-MS) spectroscopic studies. The single-crystal
X-ray structure, different noncovalent interactions, Hirshfeld surface
analysis, and density functional theory (DFT) studies of the dinuclear
complex were determined by crystallographic computational studies.
The structural study exposed that the complex consists of the penta-coordinated
double μ1.1-acetato-bridged dinuclear units of Cu(II),
and it is a centrosymmetric dimer in which the center of inversion
lies at the midpoint of two Cu(II) ions. Hirshfeld surface and DFT
studies pointed out the probable potentiality of the crystal in prospective
binding with the protein. This was experimentally verified by carrying
out the binding interaction studies against bovine serum albumin (BSA)
protein using various spectroscopic methods. It was observed that
the copper(II) complex could strongly bind to BSA and could quench
the intrinsic fluorescence of BSA. Further, the studied complex was
appraised for cell viability studies against SiHa cancer cells. It
is observed that cell viability increases with time, demonstrating
the biocompatible nature of the complex.